New antiviral strategy against human parainfluenzavirus Ghent University
Human parainfluenza viruses (hPIV) are a very important cause of paediatric hospitalization due to
acute respiratory tract infections. There are no vaccines or hPIV-targeting therapeutics available to
prevent or treat disease caused by these globally circulating respiratory viruses. The aim of this
research proposal is to develop antivirals against hPIV1 and -3, the two most important hPIV types.
These new antivirals ...